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Abstract
Background and Purpose: Anti-inflammatory cytokine and its genetic variations may play an important role in the
process of atherosclerosis. We assessed whether serum interleukin-10 (IL-10) and its genetic variations are
associated with ischemic stroke in a Chinese general population.
Methods: An epidemiological survey on cardiovascular diseases and their risk factors was carried in a general
population in Beijing in 2005. Serum IL-10, IL-6, p-selectin, soluble intercellular adhesion molecule-1 and C-reactive
protein were analyzed using ELISA kits, while three IL-10 Single Nucleotide Polymorphisms (SNP) (rs1800872,
rs1554286 and rs3021094) were genotyped in 1475 participants.
Results: A high serum IL-10 (top tertile) was significantly associated with ischemic stroke (multivariable adjusted
odds ratio (OR) =0.50; 95%CI 0.31-0.81). Rs1800872 (AA vs. AC+CC genotype, OR=1.60; 1.06-2.39), rs1554286(TT
vs. CT+CC genotype, OR=1.59; 1.06-2.39), and rs3021094 (CC/CA vs. AA genotype, OR=1.64; 1.04-2.60) were all
significantly associated with ischemic stroke even after controlling for age, sex, smoking, systolic blood pressure,
total cholesterol, glucose, body mass index and serum IL-10. The SNP score (a summary index of these SNPs) and
IL-10 (top tertile) together significantly improved the discriminative power in predicting ischemic stroke by 3.3%
(95%CI: 0.2-6.4, p=0.0398) compared to predictions based on conventional risk factors alone.
Conclusions: The lower serum IL-10 concentration and its selected genetic variations were significantly associated
with an increased likelihood of ischemic stroke in this cross-sectional study. Our results suggest that more
prospective studies should be conducted to provide stronger evidence justifying the use of IL-10 and its SNPs as new
biomarkers to identify a predisposition towards ischemic stroke.
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Introduction
Atherosclerosis is a disease process with an inflammatory
component [1]. Thus, as an important anti-inflammatory
cytokine, interleukin-10 (IL-10) has been proposed to protect
against atherosclerosis progression [2,3]. Animal experiments
have shown that the absence of IL-10 leads to an increased
susceptibility to atherosclerosis in IL-10 knockout mice [2,3].
However, there is a dearth of information on the association
between serum IL-10 and stroke in the general population.
Although the sequence of chemical base pairs and most of the
single nucleotide polymorphisms (SNP) of the IL-10 gene have
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been identified, their role in the regulation of IL-10 production
and also their influence on atherosclerosis remains largely
unknown.
The gene promoter is a region of an operon that acts as the
initial binding site for RNA polymerase to be able to regulate
the time and degree of expression of a gene [4]. Introns are
non-coding sequences that interrupt eukaryotic exons and are
removed from premature messenger RNAs by the
spliceosomal machinery before translation [5]. Although the
intron does not code protein, it has been shown to influence
gene transcription by affecting the gene space structure and/or
producing micro-RNA [6]. Compared with SNPs in exons and
promoter region, SNPs in intron regions are less frequently
studied in relation to ischemic stroke.
To date the studies which have examined the association
between rs1800872, a prevalent minor allele (~27%) in the
Chinese population situated in promoter region, and
cardiovascular disease have yielded inconsistent results [7,8].
In addition, the effects of rs1554286 and rs3021094, minor
alleles that are 28.4% and 47.8% prevalent in Chinese, which
are situated in the intron region of IL-10 gene, on serum IL-10
levels and ischemic stroke have not been previously reported.
Thus, in the current study we selected rs1800872,
rs1554286 and rs3021094 SNPs and examined the
relationships between serum IL-10, selected IL-10 gene SNPs,
and the risk of ischemic stroke using a cross-sectional study in
a general Chinese population. We also examined whether
these SNPs together with IL-10 improved the risk prediction of




The study sample was taken from the original cohort of rural
Beijing participants in the People’s Republic of China/United
States of America (PRC-USA) Collaborative Study of
Cardiovascular and Cardiopulmonary Epidemiology. A detailed
description of the goals, design and methods of PRC-USA
study has been published elsewhere [9,10]. Briefly, the current
study sample was drawn from a clustered random sample of
2313 men and women residing in 11 villages of the Shijingshan
district of Beijing who participated in the Third survey of the
PRC-USA study (1993-1994). Of the 2313 participants, 170
participants died, 105 were excluded because of missing
baseline data on cardiovascular risk factors and history of
cardiovascular disease (CVD), and the remaining 2038
participants were invited for the survey in 2005. Among 2038
eligible population, a total of 1756 (86.2%) were accessible and
participated in the field survey.
The study was approved by the Ethical Committee of Fuwai
Hospital according to the Declaration of Helsinki. Written
informed consent was obtained from all participants.
Outcome Ascertainment
People with ischemic stroke were identified using the PRC-
USA definition of ischemic stroke. The diagnosis of ischemic
stroke due to cerebral thrombosis or embolism was made by
the participant’s general practitioner or treating nursing home
physicians based on clinical findings and the computed
tomography (CT).
Genotyping
Among the field-surveyed 1756 participants, DNA was
successfully drawn from 1652 (94.1%) and assayed for
selected IL-10 gene polymorphisms. Genotyping of rs1800872
was performed by the polymerase chain reaction restriction
fragment-length polymorphism (PCR-RFLP) method [11].
Rs1554286 and rs3021094 were genotyped using ligase
detection reaction (LDR) methods in the same DNA samples.
Cytokine Measurement
Serum cytokines such as interleukin-10(IL-10), interleukin-6
(IL-6), P-selectin, soluble intercellular adhesion molecule-1 (s-
ICAM-1) and C-reactive protein (CRP) were measured using
ELISA kits according to the manufacturer’s instructions
(SUNBIO, China) in 1475 participants. The correlation
coefficient for 18 test–retest samples was 0.96 for IL-10, 0.82
for IL-6, 0.94 for P-selectin and 0.94 for s-ICAM-1 depicting
strong agreement for all (p for all <0.001). The correlation
coefficient for 44 test–retest samples was 0.994 for CRP.
Cardiovascular disease risk factor measurements
All major conventional (classical) cardiovascular risk factors
were measured using the same standard protocols as in the
previous PRC-USA surveys [9,10]. Current smoking was
defined as having smoked at least one cigarette per day for at
least the past one year. An ex-smoker was defined as an
individual who previously smoked tobacco but had stopped
smoking for at least one month. Hypertension was defined as
systolic blood pressure (SBP) ≥140mmHg or diastolic blood
pressure (DBP) ≥90 mmHg or use of antihypertensive drugs in
the past 2 weeks. Diabetes was defined as a fasting glucose
≥126mg/dL or participant use of insulin or hypoglycemic agent
[12]. Body mass index (BMI) was calculated as weight in kg/
height in m2.
Statistical analysis
The Hardy-Weinberg equilibrium was assessed using the
Chi-square test (χ2) and the SHEsis program (http://
analysis2.bio-x.cn/SHEsisMain.htm) [13]. Chi-square test (χ2)
and logistic regression models were used for dichotomous
variables. General linear models (GLM) were used to assess
the effects of SNPs and other factors on serum IL-10 using
SPSS for Windows version 16.0 (SPSS Inc., Chicago, IL).
Multiple logistic regression models were used to assess the
effects of SNPs, serum IL-10 and other factors on risk of
ischemic stroke. Haplotype analyses were performed using
SHEsis program [13,14].
We used both a mixed inheritance model (wild, mixed and
mutant genotype as three categories in SNP variable) and a
dominant inheritance model (wild/no wild genotypes as two
categories in SNP variable) to assess the effects of SNPs on
serum IL-10 and ischemic stroke respectively. In order to
assess the combined effects of all SNPs, a combined index-
IL-10 Gene and Ischemic Stroke
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SNP score was developed according to the odds ratios (ORs)
of ischemic stroke observed with each SNP. A score of SNPs
was calculated by summing the scores of rs1800872,
rs1554286 and rs3021094 as described in Supplementary A
in File S1. Among the 1475 participants who had cytokine
measurement, there were 412, 440, 144 and 479 persons
whose SNP score was 0, 1, 2 and 3 respectively. We combined
those with score 1 and 2 as one group in order to increase
statistical power. In the models, two dummy variables were
used to assess the SNP score: score 1 or 2 (yes/no) and score
3 (yes/no).
To analyze the additive contribution of IL-10 and its SNPs in
predicting the risk of ischemic stroke, we created three logistic
models using the data of 1475 participants (Supplementary B
in File S1)—the first model used IL-10(yes/no top tertile) and its
SNPs score only, the second model used conventional risk
factors only and the third model used conventional risk factors
plus IL-10(yes/no top tertile) and its SNP score. Then, the
predicted absolute risk (AR) or probability (P) of ischemic
stroke for each participant was calculated using these logistic
regression coefficients from these models in the following
equations:
Model 1: AR1 = Odds1/ (Odds1+1), where Odds1 = EXP
{(-0.65×[IL10_top_tertile(yes/no)] +0.20×[SNPscore_1_2(yes/
no)] + 0.69×[SNPscore_3(yes/no)]-2.71};
Model 2: AR2 = Odds2/ (Odds2+1), where Odd2 = EXP {0.05×
[age(yr)]-0.44×[sex(man/woman)] -0.07×[smoking(yes/no)]
+0.56×[ex-smoking(yes/no)] +0.01×[SBP (mmHg)] +0.003×
[TC(mg/dl)]-0.002×[glucose(mg/dl)]-0.004×[BMI(kg/m2)]-6.37};






In all models, yes was 1 and no was 0, EXP was a function
that EXP(numexpr)=enumexpr, where e≈2.71828.
Receiver operating characteristic curve (ROC) analysis was
used to compare the usefulness of the models in predicting the
absolute risk of ischemic stroke. Equality of the area under the
curves (AUC, or c-statistics) was tested using the
ROCCONTRAST function in logistics procedure in SAS 9.2. A
two-sided p value of <0.05 was regarded as statistically
significantly different.
Results
Characteristics of the participants with and without
ischemic stroke
Of the 1475 participants with complete data on SNPs, other
biomarkers and risk factors, 106 (7.2%) had had an ischemic
stroke. Compared to those without ischemic stroke, those who
had had an ischemic stroke were older, more likely to be men,
had higher systolic/diastolic blood pressure, higher triglyceride
levels, lower high density lipoprotein levels, a more frequent
history of hypertension and myocardial infarction, were more
likely to be on anti-inflammatory drugs and lipid lowering drugs
and had lower frequencies of the CC genotype of rs1800872
and AA genotype of rs3021094 (all p<0.05) (Table 1). The
prevalence of ischemic stroke increased with older age in both
men and women (Supplementary C in File S1).
Distribution and Linkage Correlations of SNPs
The distributions of three IL-10 gene SNPs were consistent
with the Hardy-Weinberg equilibrium in those 1369 without
ischemic stroke (p=0.28 for rs1800872, p=0.10 for rs1554286,
and p=0.25 for rs3021094) and in those 106 with ischemic
stroke (p=0.39 for rs1800872, p=0.97 for rs1554286, and
p=0.10 for rs3021094). There were significant linkage
correlations among rs1800872, rs1554286 and rs3021094
(r2=0.76 for rs1800872 vs. rs1554286, 0.30 for rs1800872 vs.
rs3021094, and 0.40 for rs1554286 vs. rs3021094, all p<0.001)
Table 1. Sample characteristics and comparison between
those participants with and without ischemic stroke.
Variables Cases (N=106)  Controls(N=1369)p values*
 Mean SD  Mean SD  
Age (years) 63.3 7.8  59.4 8.0 <0.001
Body mass index(kg/m2) 26.2 3.0  27.2 18.8 0.561
Systolic blood pressure (mmHg) 144.8 19.5  138.1 20.6 0.001
Diastolic blood pressure (mmHg) 84.5 10.3  82.3 10.6 0.036
Total cholesterol (mg/dl) 204.4 36.7  200.6 35.9 0.295
Triglyceride 162.2 102.8  139.8 88.8 0.013
high density lipoprotein
cholesterol 46.0 10.4  49.2 12.3 0.010
Glucose (mg/dl) 104.0 33.6  104.9 38.3 0.829
C-reactive protein (ug/ml) 3.79 3.32  3.47 3.78 0.395
P-selectin(ng/ml) 0.19 0.21  0.16 0.18 0.061
s-ICAM-1(ng/ml)^ 655.1 222.6  669.1 259.7 0.692
Interleukin-6(pg/ml) 18.1 24.7  17.9 20.9 0.922
Interleukin-10(pg/ml) 33.1 28.6  34.5 39.1 0.725
       
 Cases %  Controls % p values#
Interleukin-10       
 1st tertile§ 36 34.0  452 33.0  
 2nd tertile 47 44.3  448 32.7  
 3rd tertile 23 21.7  469 34.3 0.013
Men 49 46.2  466 34.0 0.011
Current smoking 29 27.4  407 29.7 0.606
Current drinking 24 22.6  327 23.9 0.772
Diabetes 23 21.7  201 14.7 0.053
Hypertension 87 82.1  688 50.3 <0.001
Myocardial infarction 10 9.4  41 3.0 <0.001
On anti-inflammatory drugs 44 41.5  226 16.5 <0.001
On lipid lowering drugs 7 6.6  41 3.0 0.044
CC genotype of rs1800872 52 49.1  808 59.0 0.045
TT genotype of rs1554286 52 49.1  545 39.8 0.062
AA genotype of rs3021094 28 26.4  494 36.1 0.045
*. Using t-test.
#Using χ2-test.
^. s-ICAM-1: soluble intercellular adhesion molecule-1.
§. Participants were divided into 3 equal tertiles of IL-10 by 10-year age groups.
doi: 10.1371/journal.pone.0074126.t001
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using SHEsis software [13,14]. The C allele of rs1800872 was
significantly linked with C allele of rs1554286 and A allele of
rs3021094 (p<0.001).
Serum IL-10 and ischemic stroke
The mean level of serum IL-10 in the total sample was
34.4±38.5pg/ml (34.0±23.8 pg/ml in men, and 34.6±44.4pg/ml
in women), which was significantly positively correlated with
age(Spearman R=0.15, p<0.001). Uni-variable analyses
showed that the mean IL-10 was not significantly different
between patients with ischemic stroke and controls (Table 1).
In order to adjust for the confounding effects of age and sex,
the sample was divided into three equal tertiles of IL-10 by 10-
year age groups. The sample was stratified into 40-, 50-, 60-,
and 70-year age groups in both men and women. Then each
group was divided into three equal tertiles of IL-10. We then
combined all first tertiles of all age-sex-groups as first tertile.
The same approach was used to categorise participants into
second and third tertiles. The distribution of age-sex-adjusted
tertiles of IL-10 was significantly different between patients with
ischemic stroke and controls (p=0.013) (Table 1). Compared to
those of the 1st+2nd tertile of IL-10, the odds ratio (OR) for
ischemic stroke was significantly decreased in those of the 3rd
tertile of IL-10 (OR=0.50, 95%CI: 0.31-0.81, p=0.005) after
adjusting for age, sex, smoking, systolic blood pressure, total
cholesterol, glucose and body mass index (Table 2).
IL-10 SNPs and ischemic stroke
The odds ratio of ischemic stroke was significantly increased
in those with AA versus AC+CC genotype of rs1800872 (OR =
1.54,95%CI:1.03-2.30,p=0.036), TT versus CC+CT genotype
of rs1554286 (OR=1.54, 95%CI: 1.02-2.30, p=0.038), and
CC/CA versus AA genotypes of rs3021094 (OR = 1.62,95%CI:
1.03-2.54, p=0.038) after adjustments were made for age, sex,
smoking, systolic blood pressure, cholesterol, glucose, and
body mass index(Table 3). The addition of serum IL-10(yes/no
Table 2. Relationship between interleukin-10 (IL-10) and
ischemic stroke in 1475 participants.
IL-10(pg/ml) Sample site Cases Rates (%) Odds ratios(95%CI)*
Per 1 SD#(38) increase 1475 106 7.2% 0.89 (0.66-1.19)
Tertile of IL-10§     
1st tertile 488 36 7.4 1
2nd tertile 495 47 9.5 1.27 (0.80-2.01)
3rd tertile 492 23 4.7 0.57 (0.33-0.99)
p for trends*   0.013 0.011
1st +2nd tertile 983 83 8.4 1
3rd tertile 492 23 4.7 0.50 (0.31-0.81)
p values*   0.008 0.005
*. Odds ratios (95%CI) and p values were calculated by multiple logistic models
after adjusting for age, sex, smoking, systolic blood pressure, cholesterol, glucose,
and body mass index.
# SD was standard deviation of IL-10.
§. Participants were divided into 3 equal tertiles of IL-10 by 10-year age groups.
doi: 10.1371/journal.pone.0074126.t002
top tertile categorical variable) into the model remained these
ORs significant (Table 3). Haplotype analyses found that ATA
and ATC haplotypes of rs1800872, rs1554286, and rs3021094
were significantly associated with ischemic stroke: a decreased
odds ratio with ATA (OR=0.68, 95%CI: 0.46-0.99, p=0.04) and
an increased odds ratio with ATC (OR=1.59, 95%CI: 1.20-2.11,
p=0.001) (Table 4).







rs1800872      
Mixed Inheritance
Model      
AA 615 54 8.8% 1.39 (0.72-2.68) 1.42 (0.73-2.76)
AC 682 40 5.9% 0.88 (0.44-1.73) 0.86 (0.44-1.71)
CC 178 12 6.7% 1 1
P for trends   0.124† 0.104 0.072
Dominant
Inheritance Model      
AA 615 54 8.8% 1.54 (1.03-2.30) 1.60 (1.06-2.39)
CC+AC 860 52 6.0% 1 1
P values   0.045‡ 0.036 0.024
rs1554286      
Mixed Inheritance
Model      
TT 597 52 8.7% 1.29 (0.70-2.37) 1.33 (0.72-2.46)
CT 676 39 5.8% 0.79 (0.42-1.48) 0.79 (0.42-1.48)
CC 202 15 7.4% 1 1
P for trends   0.127† 0.092  
Dominant
Inheritance Model      
TT 597 52 8.7% 1.54 (1.02-2.30) 1.59 (1.06-2.39)
CC+CT 878 54 6.2% 1 1
P values   0.062‡ 0.038 0.025
rs3021094      
Mixed Inheritance
Model      
AA 522 28 5.4% 1 1
AC 679 47 6.9% 1.31 (0.80-2.14) 1.33 (0.81-2.17)
CC 274 31 11.3% 2.48 (1.44-4.29) 2.59 (1.49-4.48)
P for trends   0.008† 0.003 0.002
Dominant
Inheritance Model      
AA 522 28 5.4% 1 1
CC+AC 953 78 8.2% 1.62 (1.03-2.54) 1.64 (1.04-2.60)
P values   0.045‡ 0.038 0.056
Scores of SNPs^      
0 412 22 5.3% 1 1
1-2 584 37 6.3% 1.17 (0.67-2.03) 1.19 (0.68-2.07)
3 479 47 9.8% 2.08 (1.22-3.55) 2.16 (1.26-3.70)
P for trends   0.021† 0.008 0.006
IL-10 Gene and Ischemic Stroke
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Effects of IL-10 gene polymorphisms on serum IL-10
In both univariable and age and sex adjusted general linear
models serum IL-10 levels were not significantly associated
with any polymorphisms (Supplementary D in File S1).
However, serum IL-10 level was significantly influenced by
interactions: rs1800872×age, rs1800872×IL-6, rs1554286×IL-6,
rs1554286×P-selectin, rs3021094× P-selectin (p for all <0.05)
in multiple general linear models (Supplementary E in File
S1). Figure 1 shows that IL-10 level increased with IL-6 more
steeply in those with the CC genotype of rs1800872, CC
genotype of rs1554286 and with P-selectin in those with the AA
genotype of rs3021094. Thus, when these interactions were
added into the models, serum IL-10 was significantly
associated with rs1800872, rs1554286 and rs3021094
(Supplementary D in File S1).
The value of adding IL-10 and its SNPs to classical risk
model for ischemic stroke
Model 1 containing IL-10 (yes/no top tertile) and SNPs
scores significantly predicted the likelihood of ischemic stroke
but with a modest AUC of 0.609 (95% CI 0.556-0.662,
p<0.001) (Figure 2). However, the addition of IL-10 (yes/no top
Table 3 (continued).
*. Odds ratios (95%CI) and p values were calculated by multiple logistic models
after adjusting for age, sex, smoking, systolic blood pressure, cholesterol, glucose,
and body mass index.
# Odds ratios(95%CI) and p values were calculated by multiple logistic models
after adjusting for age, sex, smoking, systolic blood pressure, cholesterol, glucose,
body mass index, and IL-10(yes/no top tertile).
† P for trends were calculated by Cochran-Armitage trend test.
‡. P values were calculated by chi-square tests.
^. Score of SNPs was summary of scores of rs1800872 (if AA, then score=1, if CC
+AC, then score=0), rs1554286 (if TT, then score=1, if CC+CT, then score=0), and
rs3021094 (if CC+AC, then score=1, if AA, then score=0). Those with score value
1 and 2 were combined into one group in order to increase the statistic power.
doi: 10.1371/journal.pone.0074126.t003
Table 4. Haplotype analysis for loci of rs1800872,
rs1554286, rs3021094 and risk of ischemic stroke.
Haplotypes (rs1800872/
rs1554286/rs3021094) Case (%) Control (%) OR(95%CI)# P for OR#
A C A 5 (0.023) 100 (0.037) 0.62 (0.25-1.55) 0.302
A C C* 1 (0.005) 1 (0.000) -  
A T A 34 (0.159) 596 (0.217) 0.68 (0.46-0.99) 0.040
A T C 108 (0.504) 1067 (0.389) 1.59 (1.20-2.11) 0.001
C C A 63 (0.294) 910 (0.332) 0.83 (0.61-1.12) 0.234
C T A* 1 (0.005) 14 (0.005) -  
C T C* 0 (0.000) 50 (0.018) -  
# Odds ratios (95%CI) and p values were calculated by SHEsis software online
(http://analysis2.bio-x.cn/myAnalysis.php) [13,14].
*. All those frequency<0.03 will be ignored in analysis.
doi: 10.1371/journal.pone.0074126.t004
tertile) and SNPs score in model 3 resulted in a significant
increase in AUC from 0.681 (95%CI 0.630 to 0.732) using
model 2 (conventional risk factors only) to 0.714 (95% CI 0.660
to 0.768). The absolute increase in AUC was 3.3% (95%CI 0.2
to 6.4, p=0.0398).
Discussion
Our results show that a higher serum IL-10 level may be
associated with a reduced risk of ischemic stroke in a general
population. This work provides new evidence backing up the
hypothesis of the protective effects of IL-10 on the
atherosclerotic process. Ross first proposed that
atherosclerosis is an inflammatory disease and not merely a
process of the accumulation of lipids within the artery wall in
1999 [1]. Since then, many studies have been conducted to
investigate the associations between markers of inflammation
and ischemic cardiovascular diseases. Interleukin(IL)-10, as an
important anti-inflammatory T-cell cytokines, had been
identified as a cytokine that regulates at least three different
types of macrophages which play an important role in
atherosclerosis [1]. Animal experiments have shown the
protective effects of IL-10 on atherosclerotic lesion formation in
IL-10 transgenic mice model and IL-10 knockout mice model
[2,3]. Moreover, in patients with acute coronary syndromes it
has been demonstrated that elevated serum IL-10 levels are
associated with a significantly improved outcome [15]. In those
> =85 years, lower IL-10 production in lipopolysaccharide-
stimulated whole-blood samples have been shown to be
significantly associated with increased incident fatal stroke [16].
Compared with stimulated IL-10 production, serum IL-10 is
easier to assess and thus may be incorporated in clinical
practice to risk stratify the likelihood of ischemic event.
Although the sequence of chemical base pairs and most
SNPs of the IL-10 gene have been identified [17], their role in
the aetiology of ischemic disease in humans is still largely
unknown. Rs1800872 is one of the most studied SNP in the
promoter region of IL-10 gene [7]. A large case-control (1107
cases, 1082 controls) study did not show a significant
association between rs1800872 and the risk of myocardial
infarction [7], but other studies have shown that the haplotype
associated with the -592A allele of rs1800872 is associated
with a higher risk of ischemic cardiovascular events [8], and
with postoperative cardiovascular events in patients with
peripheral artery disease receiving elective surgical
revascularization [18] and with coronary artery lesions in the
acute stage of Kawasaki disease [19]. Our study confirms that
the A allele of rs1800872 is significantly associated with higher
risk of ischemic stroke in a general population.
The potential mechanism of this observed association may
be that rs1800872 influences the regulation of the production of
IL-10. An extended twin study found that 50-70% of the
variance in production level of IL-10 is genetically determined
[20]. A recent small-sample study showed that serum IL-10
was significantly higher in ten rheumatoid arthritis patients
carrying the C allele of rs1800872(-592A/C) [21]. We show that
serum IL-10 level increases with serum IL-6 more rapidly in
those with AA genotype of rs1800872 (p for interaction<0.001)
IL-10 Gene and Ischemic Stroke
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Figure 1.  Age-adjusted IL-10 was significantly influenced by interaction genotypes (rs1800872, rs1554286, and rs3021094)
with IL-6 and P-selectin in 1475 participants.  Age-adjusted IL-10 and P values were calculated by multiple general linear models
(GLM) after adjusting for age.
doi: 10.1371/journal.pone.0074126.g001
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(Figure 1). Thus, although it is not known whether the
rs1800872 is alone in this association or whether it is involved
in a linkage disequilibrium with another variant, our and
previous studies suggest that it is an important genetic marker
that predisposes to ischemic stroke.
Although an intron does not code protein, it has been shown
to influence gene transcription by affecting gene space
structure and/or produce micro-RNA [6]. However, compared
with SNPs in exons and promoter region, SNPs in the intron
region are less frequently studied in relation to ischemic stroke
[7]. We show here that rs1554286 and rs3021094, located in
the intron region and highly prevalent in Chinese populations,
were significantly associated with ischemic stroke. To our
knowledge this association has not been previously reported.
We suggest here that they are important genetic markers that
Figure 2.  Receiver operating characteristic (ROC) curves and corresponding areas under the curve (AUCs) comparing
the discriminative power of IL-10(yes/no top tertile) and its SNP score only, the conventional risk score alone and their
combination.  
doi: 10.1371/journal.pone.0074126.g002
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predispose to ischemic stroke and we propose a need for more
work to explore their potential role in the aetiology of stroke.
In order to assess the combined effects of these SNPs
(rs1800872, rs1554286 and rs3021094), we developed a
combined index-an SNP score derived from the ORs of each
SNP - and found that this SNP score was significantly
associated with ischemic stroke. We also conducted haplotype
analyses and confirmed the combined effects of these three
SNPs, showing that the haplotype ATC with -592A allele of
rs1800872 was significantly associated with ischemic stroke as
previously reported [8]. We found that the influences of serum
IL-10 and the above three SNPs on ischemic stroke were
independent from each other. Therefore, we further assessed
the additional value of serum IL-10 and SNPs in predicting
ischemic stroke over and above that of a prognostic model with
conventional risk factors alone. We have shown that the
addition of serum IL-10 and the SNPs score provides a
significantly better prediction of ischemic stroke than
conventional risk factors alone. The absolute increase in AUC
was 3.3%, comparable to that of systolic blood pressure (data
were not shown) and also comparable to half of the effect size
of total burden score of carotid atherosclerosis which is
predictive of ischemic cardiovascular events [22]. Thus, IL-10
and its three SNPs have a potentially important role in clinical
practice for the estimation of an individual’s predisposition to
ischemic stroke.
This study has some limitations. Firstly, we excluded 281
participants (16% of the potentially eligible total sample of
1756) due to a lack of volume of DNA or serum resulting in no
genotyping being possible or no serum cytokine measurement
being possible. Excluded subjects had a higher risk of stroke
(they were older and had higher SBPs) (Supplementary F in
File S1). Exclusion of high risk participants however is only
likely to attenuate the strength of the associations observed
because the association between IL-10 and SNPs and
ischemic stroke is stronger in high-risk participants than in low-
risk participants in the present study (data were not shown).
Secondly, there were only 106 participants who had stroke-
thus there is the potential to have underestimated the
associations we found. Finally, the models and results may be
only applicable for this Chinese population and would need to
be assessed separately in other populations.
Despite these limitations, our study provides new evidence
that lower serum IL-10 and its genetic variations (AA genotype
of rs1800872, TT genotype of rs1554286, and CA/CC
genotype of rs3021094) are associated with an increased
likelihood of ischemic stroke. Our results suggest that more
prospective studies should be conducted to provide more data
to justify the use of IL-10 and its SNPs as new biomarkers to
identify an increased predisposition to ischemic stroke.
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